Current insulin therapy in patients with type 2 diabetes: Results of the ADHOC survey in France

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 440-445

  Penfornis, A ^a   San Galli, F ^b   Cimino, L ^c   Huet, D ^d  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Endocrinology and Fenarediam   (France)

^c Endocrinology and Metabolic Diseases   (France)

^d SAINT JOSEPH HOSPITAL   (France)

Author keywords

Diabetes; Insulin; Survey; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DRUG DOSE REGIMEN; FRANCE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE;

AGED; DIABETES MELLITUS, TYPE 2; FRANCE; GENERAL PRACTICE; HEALTH CARE SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICINE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 81055156323     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.03.001     Document Type: Article

References (14)

1. Riddle M.C. Timely addition of insulin to oral therapy for type 2 diabetes. Diabetes Care 2002, 25:395-396.
2. Wright A., Burden A.C.F., Paisey R.B., Cull C.A., Holman R.R. Sulfonylurea inadequacy. Diabetes Care 2002, 25:330-336.
3. Nathan D.M. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002, 347:1342-1349.
4. Tibaldi J. Initiating and intensifying insulin therapy in type 2 diabetes mellitus. Am J Med 2008, 121(6, Supplement 1):S20-S29.
5. Holman R.R., Farmer A.J., Davies M.J., Levy J.C., Darbyshire J.L., Keenan J.F., et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009, 361:1736-1747.
6. Jellinger P.S., Davidson J.A., Blonde L., Einhorn D., Grunberger G., Handelsman Y., et al. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocr Pract 2007, 13:260-268.
7. American Diabetes A.D.A., Association Standards of medical care in diabetes. Diabetes Care 2007, 30(suppl. 1):S4-S41.
8. Afssaps. Agence française de sécurité sanitaire des produits de santé HAS. Haute Autorité de santé. Traitement médicamenteux du diabète du type 2 (actualisation). 2006. http://www.has-sante.fr/portail/jcms/c_459270/traitement-medicamenteux-du-diabete-de-type-2.
9. Varroud-Vial M., Guerci B., Attali C., Simon D., Detournay B., Halimi S., et al. Prise en charge du diabète en France: des progrès certains. Res Diabete 2007, 4-9.
10. Institut de Veille Sanitaire. Diabète. (database on the internet). INVS. 2009. http://www.invs.sante.fr/diabete.
11. Chabrier G., Sert-Langeron C., Raccah D., Hanaire-Broutin H., Rodier M., Vaur L., et al. Instauration d'une insulinothérapie chez le diabétique de type 2 (DT2) en ambulatoire: résultats de l'étude IDAHO 1. Diabetes Metab 2004, 30:1S42.
12. Jourdan-Da Silva N. Instauration d'une insulinothérapie dans le diabète de type 2. Données épidémiologiques, étude ENTRED 2001-2003. Thesis in Medicine. Kremlin Bicêtre, France 2005.
13. Kusnik-Joinville O., Weill A., Ricordeau P., Allemand H. Treated diabetes in France in 2007: a prevalence rate close to 4% and increasing geographic disparities. Bull Epidemiol Hebd 2008, 43:409-413.
14. Kusnik-Joinville O., Weill A., Salanave B., Ricordeau P., Allemand H. Diabète traité: quelles évolutions entre 2000 et 2005 ?. Prat Organ Soins 2007, 38:1-12.